Periodontal disease is very common and might represent a non-traditional risk factor for chronic kidney disease (CKD), independently of shared risk factors. Here, the authors discuss the interplay bet...

AbstractBackground and hypothesis. The burden of chronic kidney disease is increasing driven by population aging and the rising of risk factors. In-centre

Selene T Y Teoh, Desmond Y H Yap, Tak Mao Chan; Ten Tips in Lupus Nephritis Management, Clinical Kidney Journal, , sfae376, https://doi.org/10.1093/ckj/sfa

This cohort study aims to determine whether use of glucagon-like peptide 1 receptor agonists are associated with lower risk of developing cirrhosis and its complications, including decompensation and ...

I am still in the “amazed by what AI can do” stage Here is me prompt i am teaching a class on electrolyte abnormalities for nephrologists. What would be good tricky things to teach I th…

ion and/or trafficking are key to sustain osmosis in multiple tissues. Here, we review the convergent evidence demonstrating that aquaporin-1 (AQP1) facilitates water transport across endothelial cell...

The Nephrology Nursing Shortage: Insights From a Pandemic

🌟 New Hope for Patients with HFpEF and Obesity: Tirzepatide Shows Promising Results 🌟 Exciting findings from a recent international, randomized trial…

The Glomerular Center of Northwell now runs a special monthly GN chat to discuss fun and interesting case based discussions of glomerular ...

CAR-T therapy is generating excitement for lupus, scleroderma, and other conditions as clinical trials expand

IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder with no approved therapy. Inebilizumab targets and depletes CD19+ B cells and may be effective for treat...

A machine-learning approach enables the quantification of microbial load (microbial cells per gram) in fecal samples based on the relative microbiome profile. The predicted microbial load emerged as a...

ALT: a raccoon is smiling and holding a piece of paper in its hands .

IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder with no approved therapy. Inebilizumab targets and depletes CD19+ B cells and may be effective for treat...

This cost-effectiveness study compares the clinical benefits, costs, and cost-effectiveness of populationwide chronic kidney disease screening at different initiation ages and screening frequencies.

YouTube video by The Curious Clinicians Podcast

Your signature can drive change. Sign our petition to help us convince policymakers that fighting kidney disease should be a priority.